You are here

  • Home
  • Impact
  • Publications
  • Biopharmaceutical in vitro characterisation of CPZEN-45, a drug candidate for inhalation therapy of tuberculosis

Biopharmaceutical in vitro characterisation of CPZEN-45, a drug candidate for inhalation therapy of tuberculosis

Severynse-Stevens, D. (2013). Biopharmaceutical in vitro characterisation of CPZEN-45, a drug candidate for inhalation therapy of tuberculosis. Therapeutic Delivery, 4(8), 915 - 923.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Meet the Experts

View All Experts
Diana Severynse-Stevens

Diana Severynse-Stevens

Recent Publications

Article

Accountability for SRHR in the context of the COVID-19 pandemic
Article

Adherence to buprenorphine treatment guidelines among individuals with an opioid use disorder who have private insurance
Article

Crossover between diagnostic and empirical categorizations of full and subthreshold PTSD
Chapter

Worldwide population estimates for small geographic areas

RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Accept